Concepedia

Vaibhav G. Patel

VG

Statistics

Publications

15

Citations

1.6K

H-Index

12

Active since

2016

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of California San Diego

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University

City of Hope

Vaibhav G. Patel is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, medicine, and immunotherapy.

Publications per year

2016–2024

15

Publications

15

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Andrew A. Davis, Vaibhav G. Patel · Journal for ImmunoTherapy of Cancer · 2019 · 972 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Matthew D. Galsky, Huan Wang, Noah M. Hahn et al. · European Urology · 2017 · 114 citations

Medicine, Molecular Genetics, Oncology +14

Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition

Ana Collazo-Lorduy, Mireia Castillo-Martín, Li Wang et al. · European Urology · 2016 · 90 citations · Full text

Medicine, Genetics, Oncology +17

<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade

Michael T. Schweizer, Gavin Ha, Roman Gulati et al. · JCO Precision Oncology · 2020 · 90 citations · Full text

Medicine, Cancer Biology, Oncology +15

Accelerating precision medicine in metastatic prostate cancer

Joaquı́n Mateo, Rana R. McKay, Wassim Abida et al. · Nature Cancer · 2020 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +14

1–5 of 15